JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas

Seeking AlphaNov 20 00:06

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167

Futu NewsNov 19 16:36 · Ratings

Express News | Ascendis Pharma A/S : Citigroup Cuts Target Price to $200 From $207

BreakingsNov 18 19:25

A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $153 to $207

Futu NewsNov 16 21:00 · Ratings

Acendis Pharma Shares Are Trading Higher After Stifel Maintained a Buy Rating on the Stock and Raised Its Price Target From $200 to $207.

BenzingaNov 16 01:08

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week

MT NewswiresNov 16 00:09